Group: sci.med.diseases.lyme
Lyme Disease: patient support, research & information.
Add group to favorites
Back to post list
Send new message to group Search:
Post Subject:
Might want to think about what this one means...
Might want to think about what this one means...
Action Plan (Exhibit 1):
1.C. 4. c.
Panel determinations/recommendations shall require a supermajority
vote of 75% or more of the total voting members.
Action Plan (Exhibit 1):
1.C. 4. c.
Panel determinations/recommendations shall require a supermajority
vote of 75% or more of the total voting members.
Re: Might want to think about what this one means...
On May 18, 11:09 am, the 3rd Man <sir de...@yahoo,com > wrote:
> Action Plan (Exhibit 1):
>
> 1.C. 4. c.
>
> Panel determinations/recommendations shall require a supermajority
> vote of 75% or more of the total voting members.
----------------------------------------------------------------
Now...
...if you understand what THAT means...
..,com pare the above to THIS...and ask yourself, are they just STUPID?
Or... do they think we are?
===============================================================================
"Today’s settlement marks an important victory for all patients who
suffer Lyme disease, but it is also a victory for anyone concerned
about health care,” said Johnson. “Commercially driven guidelines that
limit patient treatment options are a major issue today in healthcare,
and this decision marks an important step towards addressing it.”
"This settlement makes it clear that the IDSA guideline development
process was corrupted by a commercially driven panel that excluded
evidence supporting longer term treatment of Lyme disease,” said
attorney Lorraine Johnson, Executive Director of the California Lyme
Disease Association (CALDA). “This settlement allows suppressed
scientific viewpoints and evidence to be heard, and it is promising
news for patients.”
“We congratulate Attorney General Blumenthal for exposing the IDSA’s
conflicts of interest and helping reduce the suffering of Lyme
patients everywhere,” said Pat Smith, president of the national Lyme
Disease Association (LDA). Diane Blanchard, co-president of Time for
Lyme adds, “The IDSA guidelines are dangerous for patients who suffer
longer-term Lyme symptoms that do not fall within the IDSA’s narrow
disease definition.”
================================================================================
FOR IMMEDIATE RELEASE
CONTACT: Melissa Chefec, 203-968-6625 or Nicole Rodgers, 202-822-5200,
ext. 249/226
Settlement Announced in Landmark Investigation of Lyme Disease
Diagnosis and Treatment Guidelines
Patients’ Rights Groups Applaud Connecticut Attorney General
Blumenthal’s Settlement in Anti-trust Case Against Powerful Medical
Society
Hartford, CT, May 1, 2008 – Patients’ rights groups today hailed
Connecticut Attorney General Blumenthal’s announcement of a settlement
in a landmark antitrust investigation into the Lyme treatment
guidelines of the Infectious Diseases Society of America (IDSA).
“My office uncovered undisclosed financial interests held by several
of the most powerful IDSA panelists,” said Blumenthal. “The IDSA’s
guideline panel improperly ignored, or minimized, consideration of
alternative medical opinion and evidence regarding chronic Lyme
disease, potentially raising serious questions about whether the
recommendations reflected all relevant science.”
The groundbreaking settlement announced today forces a complete review
of the IDSA guidelines by a new panel free from conflicts of interest,
specifically excluding previous panel members. This panel will
consider a range of scientific evidence in a public forum broadcast
live over the internet and will be overseen by a specialist in
financial conflicts of interest in medicine.
“This settlement makes it clear that the IDSA guideline development
process was corrupted by a commercially driven panel that excluded
evidence supporting longer term treatment of Lyme disease,” said
attorney Lorraine Johnson, Executive Director of the California Lyme
Disease Association (CALDA). “This settlement allows suppressed
scientific viewpoints and evidence to be heard, and it is promising
news for patients.”
This is the first-ever antitrust investigation against a medical
society’s guidelines development process.
“We congratulate Attorney General Blumenthal for exposing the IDSA’s
conflicts of interest and helping reduce the suffering of Lyme
patients everywhere,” said Pat Smith, president of the national Lyme
Disease Association (LDA). Diane Blanchard, co-president of Time for
Lyme adds, “The IDSA guidelines are dangerous for patients who suffer
longer-term Lyme symptoms that do not fall within the IDSA’s narrow
disease definition.”
The IDSA guidelines are treated as mandatory within the medical
community. More than 50 physicians who use longer-term treatment
approaches have been investigated or sanctioned by state medical
boards. The guidelines can also result in financial problems for
patients, since insurance companies refuse to reimburse for longer-
term treatment and pharmacies may refuse to fill prescriptions.
The majority of individuals involved in the IDSA guidelines
development process held direct or indirect commercial interests
related to Lyme vaccines, patents, and/or test kits, and did not take
the opinions or experiences of the competing Lyme groups into account.
While the announcement of a settlement comes as a huge relief to
suffering Lyme patients, the case has much broader implications for a
health care system that often contends with conflicts-of-interest in
guideline processes – guidelines which are often used by insurance
companies to limit diagnosis and treatment options.
“Today’s settlement marks an important victory for all patients who
suffer Lyme disease, but it is also a victory for anyone concerned
about health care,” said Johnson. “Commercially driven guidelines that
limit patient treatment options are a major issue today in healthcare,
and this decision marks an important step towards addressing it.”
The national Lyme Disease Association, (LDA), CALDA, and Time for Lyme
are non-profit organizations that were founded by individuals who had
personal experience with Lyme disease, in order to address the lack of
education and support services available for this newly emerging
infection.
Last Modified: May 01, 2008
On May 18, 11:09 am, the 3rd Man <sir de...@yahoo,com > wrote:
> Action Plan (Exhibit 1):
>
> 1.C. 4. c.
>
> Panel determinations/recommendations shall require a supermajority
> vote of 75% or more of the total voting members.
----------------------------------------------------------------
Now...
...if you understand what THAT means...
..,com pare the above to THIS...and ask yourself, are they just STUPID?
Or... do they think we are?
===============================================================================
"Today’s settlement marks an important victory for all patients who
suffer Lyme disease, but it is also a victory for anyone concerned
about health care,” said Johnson. “Commercially driven guidelines that
limit patient treatment options are a major issue today in healthcare,
and this decision marks an important step towards addressing it.”
"This settlement makes it clear that the IDSA guideline development
process was corrupted by a commercially driven panel that excluded
evidence supporting longer term treatment of Lyme disease,” said
attorney Lorraine Johnson, Executive Director of the California Lyme
Disease Association (CALDA). “This settlement allows suppressed
scientific viewpoints and evidence to be heard, and it is promising
news for patients.”
“We congratulate Attorney General Blumenthal for exposing the IDSA’s
conflicts of interest and helping reduce the suffering of Lyme
patients everywhere,” said Pat Smith, president of the national Lyme
Disease Association (LDA). Diane Blanchard, co-president of Time for
Lyme adds, “The IDSA guidelines are dangerous for patients who suffer
longer-term Lyme symptoms that do not fall within the IDSA’s narrow
disease definition.”
================================================================================
FOR IMMEDIATE RELEASE
CONTACT: Melissa Chefec, 203-968-6625 or Nicole Rodgers, 202-822-5200,
ext. 249/226
Settlement Announced in Landmark Investigation of Lyme Disease
Diagnosis and Treatment Guidelines
Patients’ Rights Groups Applaud Connecticut Attorney General
Blumenthal’s Settlement in Anti-trust Case Against Powerful Medical
Society
Hartford, CT, May 1, 2008 – Patients’ rights groups today hailed
Connecticut Attorney General Blumenthal’s announcement of a settlement
in a landmark antitrust investigation into the Lyme treatment
guidelines of the Infectious Diseases Society of America (IDSA).
“My office uncovered undisclosed financial interests held by several
of the most powerful IDSA panelists,” said Blumenthal. “The IDSA’s
guideline panel improperly ignored, or minimized, consideration of
alternative medical opinion and evidence regarding chronic Lyme
disease, potentially raising serious questions about whether the
recommendations reflected all relevant science.”
The groundbreaking settlement announced today forces a complete review
of the IDSA guidelines by a new panel free from conflicts of interest,
specifically excluding previous panel members. This panel will
consider a range of scientific evidence in a public forum broadcast
live over the internet and will be overseen by a specialist in
financial conflicts of interest in medicine.
“This settlement makes it clear that the IDSA guideline development
process was corrupted by a commercially driven panel that excluded
evidence supporting longer term treatment of Lyme disease,” said
attorney Lorraine Johnson, Executive Director of the California Lyme
Disease Association (CALDA). “This settlement allows suppressed
scientific viewpoints and evidence to be heard, and it is promising
news for patients.”
This is the first-ever antitrust investigation against a medical
society’s guidelines development process.
“We congratulate Attorney General Blumenthal for exposing the IDSA’s
conflicts of interest and helping reduce the suffering of Lyme
patients everywhere,” said Pat Smith, president of the national Lyme
Disease Association (LDA). Diane Blanchard, co-president of Time for
Lyme adds, “The IDSA guidelines are dangerous for patients who suffer
longer-term Lyme symptoms that do not fall within the IDSA’s narrow
disease definition.”
The IDSA guidelines are treated as mandatory within the medical
community. More than 50 physicians who use longer-term treatment
approaches have been investigated or sanctioned by state medical
boards. The guidelines can also result in financial problems for
patients, since insurance companies refuse to reimburse for longer-
term treatment and pharmacies may refuse to fill prescriptions.
The majority of individuals involved in the IDSA guidelines
development process held direct or indirect commercial interests
related to Lyme vaccines, patents, and/or test kits, and did not take
the opinions or experiences of the competing Lyme groups into account.
While the announcement of a settlement comes as a huge relief to
suffering Lyme patients, the case has much broader implications for a
health care system that often contends with conflicts-of-interest in
guideline processes – guidelines which are often used by insurance
companies to limit diagnosis and treatment options.
“Today’s settlement marks an important victory for all patients who
suffer Lyme disease, but it is also a victory for anyone concerned
about health care,” said Johnson. “Commercially driven guidelines that
limit patient treatment options are a major issue today in healthcare,
and this decision marks an important step towards addressing it.”
The national Lyme Disease Association, (LDA), CALDA, and Time for Lyme
are non-profit organizations that were founded by individuals who had
personal experience with Lyme disease, in order to address the lack of
education and support services available for this newly emerging
infection.
Last Modified: May 01, 2008
Re: Might want to think about what this one means...
On May 18, 5:28 pm, the 3rd Man <sir de...@yahoo,com > wrote:
> On May 18, 11:09 am, the 3rd Man <sir de...@yahoo,com > wrote:> Action Plan (Exhibit 1):
>
>> “Today’s settlement marks an important victory for all patients who
> suffer Lyme disease, but it is also a victory
for anyone concerned WHAT VICTORY- NOTHING WILL COME OF IT
> about health care,” said Johnson. “Commercially driven guidelines that
> limit patient treatment options are a major issue today in healthcare,
> and this decision marks an important step towards addressing it.”
>
> The national Lyme Disease Association, (LDA), CALDA, and Time for Lyme
> are non-profit organizations that were founded by individuals who had
> personal experience with Lyme disease, in order to address the lack of
> education and support
WHAT NEWLY? EMERGING
INFECTION. DISCOVERED BY DUMB AMERICAN DRS. IN THE LATE SEVENTIES -
and if it wasn't for Polly Murray and Dr. willey Burgdorfer from
Switzerland originally ---------where would we be.......
IT'S BEEN KNOWN IN EUROPE FOR OVER 100 YRS. AND ALSO I'VE OBSERVED
THAT THE EUROPEAN DRS. (SOME) ARE GETTING INFLUENCED BY THE CREEP'S
MR. STEERE GUIDELINES. IN PARTICULAR EUCALB GROUP AND BETINA WILSKE OF
GERMANY.................YET WHEN THEY WERE PERSECUTING DR. B - HE
MENTIONED THEY WERE GIVING LONG TERM ANTIBIOTICS IN EUROPE AND ANOTHER
CREEP DATTYLER MAKES THE STATEMENT -THEY HAVE A DIFFERENT STRAIN IN
EUROPE.....YEA?
services available for this newly emerging
> infection.
>
> Last Modified: May 01, 2008
On May 18, 5:28 pm, the 3rd Man <sir de...@yahoo,com > wrote:
> On May 18, 11:09 am, the 3rd Man <sir de...@yahoo,com > wrote:> Action Plan (Exhibit 1):
>
>> “Today’s settlement marks an important victory for all patients who
> suffer Lyme disease, but it is also a victory
for anyone concerned WHAT VICTORY- NOTHING WILL COME OF IT
> about health care,” said Johnson. “Commercially driven guidelines that
> limit patient treatment options are a major issue today in healthcare,
> and this decision marks an important step towards addressing it.”
>
> The national Lyme Disease Association, (LDA), CALDA, and Time for Lyme
> are non-profit organizations that were founded by individuals who had
> personal experience with Lyme disease, in order to address the lack of
> education and support
WHAT NEWLY? EMERGING
INFECTION. DISCOVERED BY DUMB AMERICAN DRS. IN THE LATE SEVENTIES -
and if it wasn't for Polly Murray and Dr. willey Burgdorfer from
Switzerland originally ---------where would we be.......
IT'S BEEN KNOWN IN EUROPE FOR OVER 100 YRS. AND ALSO I'VE OBSERVED
THAT THE EUROPEAN DRS. (SOME) ARE GETTING INFLUENCED BY THE CREEP'S
MR. STEERE GUIDELINES. IN PARTICULAR EUCALB GROUP AND BETINA WILSKE OF
GERMANY.................YET WHEN THEY WERE PERSECUTING DR. B - HE
MENTIONED THEY WERE GIVING LONG TERM ANTIBIOTICS IN EUROPE AND ANOTHER
CREEP DATTYLER MAKES THE STATEMENT -THEY HAVE A DIFFERENT STRAIN IN
EUROPE.....YEA?
services available for this newly emerging
> infection.
>
> Last Modified: May 01, 2008
Next: Possible conflicts of interest amongst CALDA Board Of Directors
Previous: The IDSA Agreement--(for the reading comprehension impaired)
